Search
Esperion Therapeutics Inc
ESPRAdd to Watchlist
3.150USD
-0.020-0.63%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
811.73MMarket Cap
LossP/E TTM
Esperion Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Esperion Therapeutics Inc is 9.46, ranking 18 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1019.42, which is -99.97% below the recent high of -0.32 and -0.63% above the recent low of -1025.89.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
